Launch PHA: Circular Bioplastic for Pharmaceutical Packaging

Launch PHA is a fermentation-derived bioplastic platform being developed for pharmaceutical and healthcare packaging applications. The material can be tailored for different processing and performance requirements and has potential applicability in rigid packaging components produced through conventional plastics-processing methods. Target applications include bottles, containers, caps, closures, trays and other packaging components traditionally produced from petroleum-based plastics such as polypropylene, polyethylene and polystyrene. Development and validation are carried out according to the requirements of the intended customer application.

Green Product; Packaging; Product Performance; Sustainability; Launch's customer-integrated approach connects waste management directly with sustainable material production. Pharmaceutical and biomanufacturing companies can potentially convert costly organic waste streams into materials for use within their own value chains, creating a more closed-loop approach to packaging.

Key advantages include:

- Upcycles pharmaceutical and biomanufacturing waste, including yeast waste- Reduces dependence on virgin petroleum-based plastics
- Creates a pathway to lower waste-treatment and disposal costs
- Supports circular-economy and packaging-sustainability goals
- Developed around customer-specific waste streams and packaging requirements
- Reduces raw-material costs and carbon footprint through waste-derived feedstocks
- Compatible with established plastics-processing and packaging value chains

Canada; Denmark